Rajthanee Hospital PCL (BKK:RJH-R) YoY EBITDA Growth: -2.37% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:RJH-R Rajthanee Hospital PCL BKK:RJH-R
81 GF Score
Price ฿12.21
GF Value ฿20.70
! 8 Warning Signs
View Full Analysis

What is Rajthanee Hospital PCL YoY EBITDA Growth?

Rajthanee Hospital PCL BKK:RJH-R 81 YoY EBITDA Growth is -2.37% as of Mar. 2026. GuruFocus rates BKK:RJH-R with a GF Score™ of 81/100 and a GF Value™ of ฿20.70. The stock has 8 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Rajthanee Hospital PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -2.37%.

Rajthanee Hospital PCL's EBITDA per Share for the three months ended in Mar. 2026 was ฿0.45.

Rajthanee Hospital PCL YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Rajthanee Hospital PCL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rajthanee Hospital PCL YoY EBITDA Growth Chart

Rajthanee Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.24 3.10 -52.72 -1.11 -15.81

Rajthanee Hospital PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.61 -26.44 -38.72 235.51 -2.37
BKK:RJH-R
81GF Score
Rajthanee Hospital PCL BKK:RJH-R
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rajthanee Hospital PCL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Rajthanee Hospital PCL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(1.949-2.315)/ | 2.315 |
=-15.81 %

Rajthanee Hospital PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.453-0.464)/ | 0.464 |
=-2.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -2.37% mean?
Rajthanee Hospital PCL (BKK:RJH-R) has a YoY EBITDA Growth of -2.37% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Rajthanee Hospital PCL and its competitors.
Is Rajthanee Hospital PCL's YoY EBITDA Growth too high?
Rajthanee Hospital PCL's current YoY EBITDA Growth is -2.37%. Overall, Rajthanee Hospital PCL has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Rajthanee Hospital PCL's YoY EBITDA Growth compare to HCA and THC?
Rajthanee Hospital PCL's YoY EBITDA Growth of -2.37% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Rajthanee Hospital PCL and its competitors. Rajthanee Hospital PCL's current YoY EBITDA Growth is -2.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rajthanee Hospital PCL stock overvalued right now?
Rajthanee Hospital PCL (BKK:RJH-R) has a current YoY EBITDA Growth of -2.37%. The stock's GF Value™ is ฿20.70, compared to a current price of ฿12.21 — trading 41% below its estimated fair value. The current YoY EBITDA Growth is -2.37%. Rajthanee Hospital PCL's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Rajthanee Hospital PCL (BKK:RJH-R), the current YoY EBITDA Growth is -2.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rajthanee Hospital PCL (BKK:RJH-R) Overvalued in 2026?

Based on GuruFocus' analysis, Rajthanee Hospital PCL stock appears to be undervalued. The current stock price of ฿12.21 is trading 41% below its estimated GF Value™ of ฿20.70.

Key valuation signals for BKK:RJH-R:

  • YoY EBITDA Growth: -2.37%
  • GF Value™: ฿20.70 vs. price of ฿12.21 (41% below fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the BKK:RJH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rajthanee Hospital PCL Business Description

Other Exchanges RJH:Thailand
Address No. 111 Moo 3, Rojana Road, Khlong Suan Phlu Sub-district, Phra Nakhon Si Ayutthaya District, Phra Nakhon Si Ayutthaya, THA, 13000
Rajthanee Hospital PCL operates mainly in healthcare services. It is principally engaged in providing healthcare as private hospital and hospital under the affiliated of social security. The company operates inpatient medical facilities in the form of general hospitals under the names "Rajathani Hospital" and "Rajathani Rojjana Hospital". It provides healthcare services, including medical service centers and clinics, patient rooms, ambulance services, technology support, and other related facilities and services.
81GF Score

Get the complete analysis for BKK:RJH-R

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿12.21
Price
฿20.70
GF Value